Your browser doesn't support javascript.
loading
Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia.
Ware, James S; Wain, Louise V; Channavajjhala, Sarath K; Jackson, Victoria E; Edwards, Elizabeth; Lu, Run; Siew, Keith; Jia, Wenjing; Shrine, Nick; Kinnear, Sue; Jalland, Mahli; Henry, Amanda P; Clayton, Jenny; O'Shaughnessy, Kevin M; Tobin, Martin D; Schuster, Victor L; Cook, Stuart; Hall, Ian P; Glover, Mark.
Affiliation
  • Ware JS; NIHR Biomedical Research Unit in Cardiovascular Disease at Royal Brompton & Harefield, NHS Foundation Trust and Imperial College London, London, United Kingdom.
  • Wain LV; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Channavajjhala SK; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • Jackson VE; Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Edwards E; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
  • Lu R; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • Siew K; NIHR Biomedical Research Unit in Cardiovascular Disease at Royal Brompton & Harefield, NHS Foundation Trust and Imperial College London, London, United Kingdom.
  • Jia W; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Shrine N; Albert Einstein College of Medicine, Yeshiva University, New York, New York, USA.
  • Kinnear S; Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Jalland M; Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Henry AP; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
  • Clayton J; Genetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • O'Shaughnessy KM; Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Tobin MD; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
  • Schuster VL; Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Cook S; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
  • Hall IP; Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Glover M; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
J Clin Invest ; 127(9): 3367-3374, 2017 Sep 01.
Article in En | MEDLINE | ID: mdl-28783044
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazides / Sodium Chloride Symporter Inhibitors / Hyponatremia Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Invest Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazides / Sodium Chloride Symporter Inhibitors / Hyponatremia Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Invest Year: 2017 Document type: Article